These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29970440)

  • 21. Prevalence of extended-spectrum beta-lactamases in Enterobacter cloacae in Taiwan and comparison of 3 phenotypic confirmatory methods for detecting extended-spectrum beta-lactamase production.
    Yang JL; Wang JT; Lauderdale TL; Chang SC
    J Microbiol Immunol Infect; 2009 Aug; 42(4):310-6. PubMed ID: 19949754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.
    Stürenburg E; Sobottka I; Noor D; Laufs R; Mack D
    J Antimicrob Chemother; 2004 Jul; 54(1):134-8. PubMed ID: 15150168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in the resistant variants of Enterobacter cloacae selected by extended-spectrum cephalosporins.
    Fung-Tomc JC; Gradelski E; Huczko E; Dougherty TJ; Kessler RE; Bonner DP
    Antimicrob Agents Chemother; 1996 May; 40(5):1289-93. PubMed ID: 8723487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of resistance during ceftazidime and cefepime therapy in a murine peritonitis model.
    Pechère JC; Vladoianu IR
    J Antimicrob Chemother; 1992 May; 29(5):563-73. PubMed ID: 1624394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Snapshot of Co-Resistance to Carbapenems and Tigecycline in Clinical Isolates of Enterobacter cloacae.
    Huang LF; Lee CT; Su LH; Chang CL
    Microb Drug Resist; 2017 Jan; 23(1):1-7. PubMed ID: 27136494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of resistance in clinical isolates of Pseudomonas aeruginosa less susceptible to cefepime than to ceftazidime.
    Campo Esquisabel AB; Rodríguez MC; Campo-Sosa AO; Rodríguez C; Martínez-Martínez L
    Clin Microbiol Infect; 2011 Dec; 17(12):1817-22. PubMed ID: 21599797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
    Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
    J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended double disc synergy testing reveals a low prevalence of extended-spectrum beta-lactamases in Enterobacter spp. in Vienna, Austria.
    Apfalter P; Assadian O; Daxböck F; Hirschl AM; Rotter ML; Makristathis A
    J Antimicrob Chemother; 2007 May; 59(5):854-9. PubMed ID: 17347178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Broader distribution of plasmid-mediated quinolone resistance in the United States.
    Robicsek A; Sahm DF; Strahilevitz J; Jacoby GA; Hooper DC
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3001-3. PubMed ID: 15980384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The inducibility of Amp C enzyme of Enterobacter cloacae and its susceptibility to enzyme inhibitor].
    Zhang Y; Li J; Zhao M
    Zhonghua Yi Xue Za Zhi; 2001 Feb; 81(4):227-30. PubMed ID: 11798880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Characterization of gene expression associated with both the AcrAB/TolC system and the membrane permeability, in Salmonella spp isolates with and without gyrA mutation].
    Galiana A; Sánchez-Guillén L; Rodríguez JC; Cremades R; Santibañez M; Ferrari R; Ruiz-García M; López P; Royo G
    Rev Esp Quimioter; 2014 Dec; 27(4):239-43. PubMed ID: 25536427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The dissemination mode of drug-resistant genes in Enterobacter cloacae.
    Liu J; Zeng T; Su G; Lin LY; Zhao Y; Yang WQ; Xie WX; Zhao ZG; Li GM
    Indian J Med Microbiol; 2015 Feb; 33 Suppl():87-92. PubMed ID: 25657163
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Gravey F; Cattoir V; Ethuin F; Fabre L; Beyrouthy R; Bonnet R; Le Hello S; Guérin F
    Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32778545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The origin, by mutation, of high level resistance to ceftazidime and cefotaxime in a clinical isolate of Enterobacter cloacae.
    Blahová J; Lesická-Hupková M; Králiková K; Krcméry V; Mikovicová A
    J Chemother; 1996 Aug; 8(4):266-9. PubMed ID: 8873831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterisation and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacter cloacae isolated from a district teaching hospital in Taiwan.
    Yu WL; Cheng KC; Chi CJ; Chen HE; Chuang YC; Wu LT
    Clin Microbiol Infect; 2006 Jun; 12(6):579-82. PubMed ID: 16700709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Beta-lactam resistance in aquatic Enterobacter cloacae strains using phenotypic and genotypic criteria].
    Lazăr V; Cernat R; Balotescu C; Cotar A; Coipan E; Cojocaru C
    Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):185-91. PubMed ID: 15085610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of AraC/XylS stress response regulators in two distinct carbapenem-resistant Enterobacter cloacae ST89 biotypes.
    Majewski P; Gutowska A; Sacha P; Schneiders T; Talalaj M; Majewska P; Zebrowska A; Ojdana D; Wieczorek P; Hauschild T; Kowalczuk O; Niklinski J; Radziwon P; Tryniszewska E
    J Antimicrob Chemother; 2020 May; 75(5):1146-1150. PubMed ID: 31960042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence of SHV-12 extended spectrum beta-lactamase among clinical isolates of Enterobacter cloacae in Tunisia.
    Lahlaoui H; Anis BH; Mohamed K; Mohamed BM
    Microb Pathog; 2012 Aug; 53(2):64-5. PubMed ID: 22543154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Markedly different rates and resistance profiles exhibited by seven commonly used and newer beta-lactams on the selection of resistant variants of Enterobacter cloacae.
    Chan WC; Li RC; Ling JM; Cheng AF; Schentag JJ
    J Antimicrob Chemother; 1999 Jan; 43(1):55-60. PubMed ID: 10381101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic resistance in Enterobacter cloacae strains with derepressed/partly derepressed/inducible AmpC and extendedspectrum beta-lactamases in Zenica-Doboj Canton, Bosnia and Herzegovina.
    Uzunović S; Ibrahimagić A; Bedenić B
    Med Glas (Zenica); 2018 Feb; 15(1):37-45. PubMed ID: 29214986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.